FDA Webview
X
latest-news

FDA approves Ionis Pharmaceuticals’ Zanvastro (zilganersen) injection for treating Alexander disease in pediatric and adult patients.

latest-news

A Crowell & Moring analysis says FDA may increase regulatory scrutiny for user-facing GenAI-enabled devices.

LATEST NEWS

View All
motusgi
Ionis Pharma’s Alexander Disease Drug Approved

FDA approves Ionis Pharmaceuticals’ Zanvastro (zilganersen) injection for treating Alexander disease in pediatric and adult patients.

motusgi
GenAI Devices to See Increased Scrutiny: Law Firm

A Crowell & Moring analysis says FDA may increase regulatory scrutiny for user-facing GenAI-enabled devices.

motusgi
FDA Helping to Increase Supply of Estradiol Patches

FDA says helping to increase supplies of estradiol transdermal patches after reports that some patients are having difficulty finding their usual products at pharmacies.In a 9/3 update`

motusgi
Heartvue’s MRI-Reviewing Software Cleared

FDA grants Heartvue.ai a 510(k) clearance for its Heartvue.Proton, a machine learning–powered software for viewing, post-processing, and quantitative evaluation of cardiovascular magnetic resonance images.

newsletter-first

FDA Webview Free Daily e-Newsletter

Free Sign-Up

Animal Drugs

View All
medical-devices
Read More
Antimicrobial Animal Drug Finalized Safety Guidance

FDA issues a finalized guidance on evaluating the safety of antimicrobial animal drugs based on their role in human medicine.

medical-devices
Read More
Petition Urges FDA to Restrict Antibiotic Use in Animals

A coalition of 65 health, environmental, consumer, farming, and animal welfare organizations petition FDA to withdraw approvals for the routine use of...

medical-devices
Read More
FDA Authorizes 1st Generic Animal Drug for New World Screwworm

FDA authorizes Felix Pharmaceuticals’ generic nitenpyram tablets to treat New World screwworm infestations in dogs and cats.

medical-devices
Read More
Open Letter to Trump Urges FDA Push on Rare Diseases

In an opern letter to president Trump, rare disease advocates urge him to push FDA to accelerate approvals for treatments targeting fatal genetic diso...

Biologics

View All
medical-devices
Read More
uniQure Files BLA for Huntington’s Gene Therapy

Following a course reversal by FDA, uniQure files a BLA seeking accelerated approval of ifezuntirgene inilparvovec (AMT-130), an investigational gene ...

medical-devices
Read More
FDA Approves Updated Covid-19 Vaccines for Upcoming Season

FDA approves updated Covid-19 vaccines from Moderna, Pfizer-BioNTech and Novavax/Sanofi for the upcoming vaccination season.

medical-devices
Read More
FDA Approves First Drug for Warm Autoimmune Hemolytic Anemia

FDA approves a Janssen Biotech BLA for Imaavy (nipocalimab-aahu) injection for warm autoimmune hemolytic anemia in adult and pediatric patients.

medical-devices
Read More
Jemperli sBLA for Rectal Cancer Accepted for Priority Review

FDA accepts for priority review a GSK supplemental BLA for Jemperli (dostarlimab) for certain patients with previously untreated Stage II and III loca...

FDA General

View All
medical-devices
Read More
Food & Drug Legal Icon Peter Barton Hutt Passes Away at 91

Former FDA chief counsel Peter Barton Hutt passes away at the age of 91.

medical-devices
Read More
FDA, SEC Sign MOU on Sharing Info on Medical-Product Companies

FDA and the U.S. Securities and Exchange Commission sign an MOU to strengthen cooperation and share information involving companies and products regu...

medical-devices
Read More
HHS to Appoint 2 New FDA Deputy Commissioners: CNBC

CNBC reports that HHS plans to appoint two new FDA deputy commissioners in hopes of exerting more influence over the agency.

medical-devices
Read More
Webinar on FDA’s Bayesian Draft Guidance

FDA announces a 10/14 Webinar on its recent draft guidance on Use of Bayesian Methodology in Clinical Trials of Drugs and Biologics.

newsletter-second

FDA Webview Free Daily e-Newsletter

Free Sign-Up

Federal Register

View All
motusgi
Read More
FDA Moves to Cement Complete Response Letter Transparency Policy

FDA looks to formalize one of its most significant transparency initiatives in decades: the public r...

motusgi
Read More
FDA Warns Brazilian Drug Maker Over Records Request

FDA sends a Warning Letter to Brazilian over-the-counter drug manufacturer Aeroflex Industria de Aer...

motusgi
Read More
FDA Delays Review Action on Alzheimer’s Drug

FDA delays by three months its decision on Eisai and Biogen's subcutaneous starting-dose formulation...

motusgi
Read More
Alnylam Pharma’s Web Promo is Misleading: FDA

FDA sends an untitled letter to Alnylam Pharmaceuticals, citing misleading promotional claims on a c...

Human Drugs

View All
motusgi
Read More
Ionis Pharma’s Alexander Disease Drug Approved

FDA approves Ionis Pharmaceuticals’ Zanvastro (zilganersen) injection for treating Alexander disease...

motusgi
Read More
FDA Helping to Increase Supply of Estradiol Patches

FDA says helping to increase supplies of estradiol transdermal patches after reports that some patie...

motusgi
Read More
AstraZeneca Wins Accelerated Approval for Breast Cancer Drug

FDA grants AstraZenenca an accelerated approval for Etcamah (camizestrant), an estrogen receptor ant...

motusgi
Read More
FDA Strengthening Good Clinical Practice Oversight

Four FDA senior officials explain how the agency is strengthening its good clinical practice oversig...

Marketing

View All
motusgi
Read More
FDA Hits Alar Pharmaceuticals Experimental Ketamine Promotion

FDA issues Alar Pharmaceuticals an untitled letter over promotional materials for its investigationa...

motusgi
Read More
FDA Promotion Crackdown Enters New Phase: Attorneys

Attorneys from Arnall Golden Gregory examine and offer advice on FDA’s intensified scrutiny of drug ...

motusgi
Read More
FDA Plan Would ‘Fundamentally Reshape’ Drug Ads

Two Sheppard attorneys say an FDA proposal to require complete safety and risk information within th...

motusgi
Read More
FDA Cites Sanofi Over Misleading Beyfortus Promotional Emails

FDA sends an untitled letter to Sanofi Vaccines U.S., alleging that promotional emails for its respi...

Medical Devices

View All
motusgi
Read More
GenAI Devices to See Increased Scrutiny: Law Firm

A Crowell & Moring analysis says FDA may increase regulatory scrutiny for user-facing GenAI-enabled ...

motusgi
Read More
Heartvue’s MRI-Reviewing Software Cleared

FDA grants Heartvue.ai a 510(k) clearance for its Heartvue.Proton, a machine learning–powered softwa...

motusgi
Read More
Boston Scientific Recalls Spinal Cord Stimulator Leads

Boston Scientific recalls all unused spinal cord stimulator Infinion CX Leads after determining that...

motusgi
Read More
Early Alert: Draeger Breathing Circuit Issue

CDRH issues an early alert based on a Draeger letter to customers recommending certain VentStar Resu...